NEUCA S.A. ZY 1

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, NEUCA S.A. ZY 1 has already paid €4.12 in dividends. The last payout was in July.

Financials

In the last quarter, NEUCA S.A. ZY 1 had revenue of €830.65m and net profit of €9.49m

(EUR)	June 2026	YoY
Revenue	830.65m	7.89%
Gross profit	98.11m	11.13%
Net profit	9.49m	102.98%
EBITDA	23.94m	20.72%

Fundamentals

Metric	Value
Market capitalization	€714.47m
Number of shares	4.52m
52-week high/low	€194.79 - €142.51
Dividend yield	2.60%
Dividends TTM	€4.12
Beta	0.46
P/E ratio	16.13
PEG ratio	0.37
P/B ratio	2.85
P/S ratio	0.22

Company profile

NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. It also provides logistic and distribution services, such as national and international transport; lease space for pharmaceutical wholesalers; import and custom; product packaging and repackaging; intervention channel; and tailored services. In addition, it is involved of provision advertising and marketing services; pharmaceutical products under its own brand; and operation of outpatient care clinics, as well as provision of clinical trials and telemedicine. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.